Walmsley Shakes Up GSK; Cuts More Than 30 Drug Development Programs

 
• By Lucie Ellis-Taitt
Blocks
Walmsley to set GSK on a new path with R&D shake up • Source: Shutterstock

More from Earnings

More from Business